Hanyuan Liu

1.7k total citations · 1 hit paper
59 papers, 935 citations indexed

About

Hanyuan Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hanyuan Liu has authored 59 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Hanyuan Liu's work include Circular RNAs in diseases (9 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Hanyuan Liu is often cited by papers focused on Circular RNAs in diseases (9 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Hanyuan Liu collaborates with scholars based in China, Malaysia and United Kingdom. Hanyuan Liu's co-authors include Weiwei Tang, Dawei Rong, Guoqiang Sun, Zhiying Zheng, Xuehao Wang, Xiaopei Hao, Guangshun Sun, Xiangyi Kong, Yao Zhang and Haibo Yu and has published in prestigious journals such as Oncogene, ACS Applied Materials & Interfaces and Applied Energy.

In The Last Decade

Hanyuan Liu

56 papers receiving 911 citations

Hit Papers

Inhibition of APOC1 promotes the transformation of M2 int... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanyuan Liu China 18 416 287 206 188 184 59 935
Jiahao Jiang China 19 586 1.4× 304 1.1× 142 0.7× 354 1.9× 203 1.1× 67 1.5k
Kaiwen Li China 19 330 0.8× 150 0.5× 279 1.4× 178 0.9× 117 0.6× 88 1.1k
Junhui Hu China 24 890 2.1× 603 2.1× 224 1.1× 186 1.0× 110 0.6× 48 1.5k
Fabian Spill United Kingdom 15 381 0.9× 173 0.6× 100 0.5× 368 2.0× 168 0.9× 33 1.2k
Xiangyu Zeng China 18 365 0.9× 133 0.5× 179 0.9× 196 1.0× 90 0.5× 63 955
Zhuang Tang China 21 323 0.8× 208 0.7× 200 1.0× 90 0.5× 100 0.5× 61 1.0k
Ryo Ohta Japan 17 328 0.8× 157 0.5× 81 0.4× 251 1.3× 114 0.6× 92 961
Liye Zhang China 20 944 2.3× 148 0.5× 64 0.3× 153 0.8× 83 0.5× 65 1.4k
Kuan Jiang China 25 1.1k 2.5× 523 1.8× 95 0.5× 165 0.9× 111 0.6× 64 1.7k
Erhui Jiang China 18 567 1.4× 431 1.5× 61 0.3× 274 1.5× 131 0.7× 47 1.1k

Countries citing papers authored by Hanyuan Liu

Since Specialization
Citations

This map shows the geographic impact of Hanyuan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanyuan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanyuan Liu more than expected).

Fields of papers citing papers by Hanyuan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanyuan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanyuan Liu. The network helps show where Hanyuan Liu may publish in the future.

Co-authorship network of co-authors of Hanyuan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Hanyuan Liu. A scholar is included among the top collaborators of Hanyuan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanyuan Liu. Hanyuan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Xi, Mengfei Zhao, Hanyuan Liu, et al.. (2025). Discovery of viruses and bacteria associated with swine respiratory disease on farms at a nationwide scale in China using metatranscriptomic and metagenomic sequencing. mSystems. 10(2). e0002525–e0002525. 1 indexed citations
2.
Zhao, Zhen, Yujie Zhou, Peng Lv, et al.. (2024). NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization. Cancer Letters. 597. 217059–217059. 19 indexed citations
3.
Wang, Lan, et al.. (2024). Construction of multiscale hierarchical porous titanium scaffolds and in vitro evaluation of osteogenic differentiation. Materials & Design. 249. 113534–113534. 4 indexed citations
4.
5.
Liu, Hanyuan, Xuelin Yao, Ying Zhou, & Liang Chen. (2024). CircRNA-based therapeutics: Current opinions and clinical potential. 2(3). 100081–100081. 1 indexed citations
6.
Liu, Hanyuan, et al.. (2024). Texture Evolution and Plastic Deformation Mechanism of Cold-Drawn Co-Cr-Ni-Mo Alloy. Metals. 14(6). 642–642.
8.
Wang, Yucong, Xiaolin Wang, Hanyuan Liu, et al.. (2024). HNRNPD regulates the biogenesis of circRNAs and the ratio of mRNAs to circRNAs for a set of genes. RNA Biology. 21(1). 834–848. 6 indexed citations
9.
Sun, Guangshun, Yuliang Wang, Hanyuan Liu, et al.. (2023). CHSY1 promotes CD8+ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR/Cas9 screening. Journal of Experimental & Clinical Cancer Research. 42(1). 248–248. 35 indexed citations
10.
Li, Yan, Fenglin Huang, Hongzhou Cai, et al.. (2023). Immunotherapy: Review of the Existing Evidence and Challenges in Breast Cancer. Cancers. 15(3). 563–563. 6 indexed citations
11.
Qian, Lili, Hanyuan Liu, Zhihao Xu, et al.. (2023). Circular RNA ARHGAP5 inhibits cisplatin resistance in cervical squamous cell carcinoma by interacting with AUF1. Cancer Science. 114(4). 1582–1595. 9 indexed citations
12.
Zhang, Xuemei, Qianxi Yang, Huake Yang, et al.. (2023). Omnidirectional water wave-driven triboelectric net-zero power smart ocean network: An advanced hardware solution to long-distance target detection. Nano Energy. 114. 108614–108614. 26 indexed citations
13.
Tang, Weiwei, Hanyuan Liu, Xiao Li, et al.. (2023). Upregulation of APOC1 Promotes Colorectal Cancer Progression and Serves as a Potential Therapeutic Target Based on Bioinformatics Analysis. Journal of Oncology. 2023. 1–13. 6 indexed citations
14.
Rong, Dawei, Yuliang Wang, Li Liu, et al.. (2023). GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway. Journal for ImmunoTherapy of Cancer. 11(2). e005126–e005126. 17 indexed citations
15.
Li, Zhouxiao, et al.. (2023). Extracellular RNA in melanoma: Advances, challenges, and opportunities. Frontiers in Cell and Developmental Biology. 11. 6 indexed citations
16.
Hao, Xiaopei, Yao Zhang, Xiaoli Shi, et al.. (2022). CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ. Journal of Experimental & Clinical Cancer Research. 41(1). 281–281. 57 indexed citations
17.
Sun, Guangshun, Hanyuan Liu, Jie Zhao, et al.. (2022). Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy. Journal for ImmunoTherapy of Cancer. 10(12). e005655–e005655. 29 indexed citations
18.
Li, Xiao, Liangliang Wu, Zhiying Zheng, et al.. (2022). Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy. Journal of Oncology. 2022. 1–12. 4 indexed citations
19.
Li, Jinguang, Rui Hu, Hanyuan Liu, et al.. (2021). Plasma electrolytic deposition of α-Al2O3 on TiNb fibres and their mechanical properties. Ceramics International. 47(23). 32915–32926. 7 indexed citations
20.
Liu, Hanyuan, et al.. (2019). Flow stress characteristics and microstructure evolution during hot compression of Nb-47Ti alloy. Journal of Alloys and Compounds. 797. 735–743. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026